To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Clinical trial NCT06038916 · COMPLETED
Trial details
- NCT number
- NCT06038916
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-09
- Primary completion
- 2025-03-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.